Lv11
100 积分 2024-04-18 加入
A first-in-human phase 1 study of a novel PARP7 inhibitor RBN-2397 in patients with advanced solid tumors
2小时前
求助中
Serum GDNF levels as predictors of subjective cognitive complaints in male subjects with major depressive disorder
19天前
已完结
Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial
2个月前
已完结
Secukinumab long-term safety experience: A pooled analysis of 10 phase II and III clinical studies in patients with moderate to severe plaque psoriasis
2个月前
已完结
Secukinumab, a fully human anti‐interleukin‐17A monoclonal antibody, exhibits minimal immunogenicity in patients with moderate‐to‐severe plaque psoriasis
2个月前
已完结
Secukinumab, a fully human anti‐interleukin‐17A monoclonal antibody, exhibits minimal immunogenicity in patients with moderate‐to‐severe plaque psoriasis
2个月前
已关闭
Pharmacokinetics and absolute bioavailability of mepolizumab following administration at subcutaneous and intramuscular sites
2个月前
已完结
Secukinumab exploratory study to investigate distribution in dermal interstitial fluid using dermal open flow microperfusion after single 300-mg subcutaneous administration: Pharmacokinetic assessment in healthy volunteers and patients with moderate to severe plaque-type psoriasis
2个月前
已完结
皖公网安备34019202002308
